Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma [Phase 3]
A Phase 3 trial comparing surgery with or without combination chemotherapy for patients with lung metastases from soft tissue sarcoma has co…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
The document reports the completion of a Phase 2 trial evaluating soblidotin in patients with advanced or metastatic soft tissue sarcoma, sp…
-
CLINICAL_TRIALS research · 2012-05-08Clinical Trial Update: Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma
This clinical trial update evaluates the contribution of F18-FDG PET/CT for early assessment of pazopanib efficacy in patients with advanced…
-
FDA approval · 2012-04-26FDA Approved: VOTRIENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for VOTRIENT (pazopanib hydrochloride) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma [Phase 2]
This update reports the completion of a Phase 2 trial evaluating neoadjuvant high-dose ifosfamide with concurrent radiotherapy in soft tissu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-02-17FDA Approved: HALAVEN — Supplemental Application (BSP Pharmaceuticals SpA)
FDA approved a supplemental application for HALAVEN (eribulin mesylate) submitted by BSP Pharmaceuticals SpA.
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis [Phase 2, Phase 3]
Clinical trial update on the Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for detecting chemotherapy-induced apoptosis across pha…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 3]
A Phase 3 trial comparing ifosfamide versus doxorubicin in patients with advanced or metastatic soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-21Clinical Trial Update: Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy [Phase 3]
Phase 3 trial comparing pazopanib versus placebo in soft tissue sarcoma patients whose disease progressed after prior therapy; results were …
-
FDA label_change · 2011-10-21FDA Approved: VOTRIENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for VOTRIENT (pazopanib hydrochloride) from Novartis Pharmaceuticals Corporation, resulting in chang…
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas [Phase 2]
Phase 2 trial of cetuximab in patients with metastatic and/or locally advanced soft tissue and bony sarcomas has completed and posted result…
-
CLINICAL_TRIALS other · 2011-09-01Clinical Trial Update: YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access
This update reports that the single-patient compassionate use/expanded access program for Yondelis (trabectedin) in soft tissue sarcoma is n…
-
CLINICAL_TRIALS research · 2011-07-06Clinical Trial Update: A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall [Phase 2]
This Clinical Trial Update describes a Phase 2 protocol from the Scandinavian Sarcoma Group for patients with high-risk soft tissue sarcoma …
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma [Phase 2]
This update reports completion of a Phase 2 trial evaluating neoadjuvant and adjuvant chemotherapy for high-risk soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of sunitinib and radiation in patients with resectable soft tissue sarcoma; the curren…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating chemotherapy, radiation therapy, and sargramostim given before and after surgery for soft tissue sarcoma that is su…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery [Phase 2]
Phase 2 trial of sorafenib combined with ifosfamide for high-grade soft tissue sarcoma or bone sarcoma resectable by surgery; study terminat…
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
A completed pilot clinical trial evaluating whether exposure to environmental pollutants is linked to the risk of soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2010-10-11Clinical Trial Update: Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors [Phase 1, Phase 2]
This clinical trial update summarizes a Phase 1/2 study of tandem peripheral blood stem cell rescue for high-risk solid tumors. Eligible con…
-
CLINICAL_TRIALS trial_result · 2010-09-02Clinical Trial Update: BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas [Phase 2]
Phase 2 trial of sorafenib (BAY-43-9006) in advanced soft tissue sarcoma has completed enrollment, according to the trial update.
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma [Phase 2]
Phase 2 trial of pazopanib in relapsed or refractory soft tissue sarcoma has completed and results were posted in January 2010.
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients [Phase 1, Phase 2]
A Phase 1/2 study evaluating TLC D-99 in combination with Ifosfamide for metastatic soft tissue sarcoma has completed.
-
CLINICAL_TRIALS research · 2009-10-20Clinical Trial Update: Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas [Phase 2]
Phase 2 clinical trial evaluating hematopoietic stem cell transplantation from an HLA-compatible donor in patients with Ewing sarcoma and so…
-
FDA approval · 2009-10-19FDA Approved: VOTRIENT — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved VOTRIENT (pazopanib hydrochloride) under an Original Application for cancer indications, marking pazopanib’s initial approval.
-
CLINICAL_TRIALS trial_result · 2009-04-02Clinical Trial Update: a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4 [Phase 2]
A multicenter Phase 2 trial evaluating treatment for children and adolescents with Stage 4 soft tissue sarcoma has completed (NCT00130858).